Vertex Pharmaceuticals Incorporated Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Vertex Pharmaceuticals Incorporated stock price down 0.664% on Friday
(Updated on Jun 28, 2024)
The Vertex Pharmaceuticals Incorporated stock price fell by -0.664% on the last day (Friday, 28th Jun 2024) from 444.30€ to 441.35€. During the last trading day the stock fluctuated 0.725% from a day low at 441.15€ to a day high of 444.35€. The price has fallen in 6 of the last 10 days and is down by -1.97% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -203 shares and in total, 74 shares were bought and sold for approximately 32.66€ thousand.
The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.04% during the next 3 months and, with a 90% probability hold a price between 538.42€ and 581.71€ at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
VX1.F Signals & Forecast
The Vertex Pharmaceuticals Incorporated stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 441.13€ and 427.35€. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 14, 2024, and so far it has fallen -1.97%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock
Vertex Pharmaceuticals Incorporated finds support from accumulated volume at 429.75€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved 3.20€ between high and low, or 0.725%. For the last week the stock has had daily average volatility of 1.19%.
Our recommended stop-loss: 422.99€ (-4.16%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 21 days ago.)
Trading Expectations (VX1.F) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect Vertex Pharmaceuticals Incorporated to open at 442.28€, and during the day (based on 14 day Average True Range), to move between 434.48€ and 448.22€, which gives a possible trading interval of +/-6.87€ (+/-1.56%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 3.11% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at 442.00€ (0.15%) than the support at 429.75€ (2.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Vertex Pharmaceuticals Incorporated stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vertex Pharmaceuticals Incorporated stock to perform well in the short-term.
Current score: 1.757 Buy Candidate Unchanged
Predicted Opening Price for Vertex Pharmaceuticals Incorporated of Monday, July 1, 2024
| Fair opening price July 1, 2024 | Current price |
|---|---|
| 442.28€ ( 0.211%) | 441.35€ |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for VX1.F
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 445.48 | 0.94% |
| R2 | 444.26 | 0.660% |
| R1 | 443.51 | 0.488% |
| Price | 441.35 | |
| S1 | 441.06 | -0.0655% |
| S2 | 440.31 | -0.237% |
| S3 | 439.08 | -0.514% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 445.00 | 0.83% |
| R2 | 444.30 | 0.668% |
| R1 | 442.00 | 0.147% |
| Price | 441.35 | |
| S1 | 429.75 | -2.63% |
| S2 | 374.85 | -15.07% |
| S3 | 374.65 | -15.11% |
FAQ
Click here for our free guide on how to buy Vertex Pharmaceuticals Incorporated Stock.
